detecting peripheral blood involvement by plasma cell proliferative disorders
establishing the diagnosis of and determining prognosis for plasma cell proliferative disorders
Flow Cytometry
外周血标签指数
whole blood
标本必须在收集的72小时内到达。
date and time of collection是必要的。
Container/Tube:
首选:Green top (sodium heparin)
Acceptable:lavender top (EDTA)
specimen Volume:10 mL
收集说明:
1.不要离心。
2. Send whole blood specimen in original tube.do not aliquot.
我f not ordering electronically,complete, print, and send a血液病理/细胞遗传学测试请求(T726) with the specimen.
4 mL
严重的溶血 | 拒绝 |
specimen Type | temperature | time | 特殊容器 |
---|---|---|---|
whole blood | Ambient (preferred) | 72 hours | |
refrigerated | 72 hours |
detecting peripheral blood involvement by plasma cell proliferative disorders
establishing the diagnosis of and determining prognosis for plasma cell proliferative disorders
等离子体细胞增殖疾病是一组血液学肿瘤,所有这些都是源自克隆血浆细胞的。这些疾病表现出广泛的生物学活性,范围从具有不确定意义的单克隆性胶质病,这种疾病进展率较低,多发性骨髓瘤通常是一种疾病,这种疾病通常是侵略性的,长期生存率较差。检测血浆细胞免疫球蛋白轻链限制(即,主要的kappa或主要lambda光链的存在)是评估血浆细胞克隆性的重要因素,因此建立了诊断。此外,这些疾病的周围血液参与更大程度与更具侵略性的疾病类型有关,因此是一种不利的预后指标。
Flow cytometric immunophenotyping (FCIP) is a recognized method for detecting plasma cell immunoglobulin light chain restriction. However, short comings of the traditionally performed technique include relative insensitivity and consistent underestimation of the number of clonal plasma cells present. Both short comings are likely attributable to limitations of the instruments and antibodies used, as well as the presence of intraclonal phenotypic heterogeneity, which creates difficulties in accurately detecting and enumerating all of the clonal plasma cells. For this reason, the FCIP plasma cell clonality assessment previously performed in our laboratory was supplemented with a slide-based immunofluorescence technique.
However, recent advances in flow cytometry have led to the development of more powerful instruments and antibody reagents that allow for the use of greater antibody combinations and increased resolution of the data. With these tools, the ability of FCIP to detect and enumerate plasma cell clones has been greatly enhanced, allowing us to discontinue the supplemental, labor-intensive, slide-based plasma cell evaluation in peripheral blood specimens.
the following algorithms are available:
将提供解释性报告。
我n normal peripheral blood specimens, no clonal plasma cells are present (polytypic or too few to detect).
plasma cells are CD38 and CD138 positive.
normal (polyclonal, nonneoplastic) plasma cells are typically CD19-positive, whereas neoplastic (clonal) plasma cells typically are CD19-negative. CD19 expression is especially helpful in distinguishing clonal from nonclonal plasma cells when few analyzable cells are present.
Cd45 may be expressed by both normal and neoplastic plasma cells. In some plasma cell proliferative disorders there are both CD45-positive and CD45-negative subsets within the clonal cell population.
这些抗原的评估有助于鉴定异常的浆细胞,但是,它们不会独立报告。
没有明显的警告陈述
Chakraborty R, Muchtar E, Kumar SK, et al: Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era. Blood Cancer J. 2016 Dec;6(12):e512. doi: 10.1038/ bcj.2016.117
serial measurements of circulating plasma cells before and after induction therapy have an independent prognostic impact in patients with multiple myeloma undergoing upfront autologous transplantation.血液学。2017年8月; 102(8):1439-1445
3。Evans LA,Jevremovic D,Nandakumar B等人:利用多参数流式细胞仪的诊断,原发性浆细胞白血病患者。Am J Hematol。2020 Jun; 95(6):637-642。doi:10.1002/ajh.25773
4. Gonsalves WI, Jevremovic D, Nandakumar B, et al: Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells. Am J Hematol. 2020 Mar;95(3):310-315. doi: 10.1002/ajh.25709
5. Ravi P, Kumar SK, Roeker L, et al. Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma. Blood Cancer J. 2018 Nov;8(12):116
血浆细胞免疫球蛋白轻链限制评估是通过6色流式细胞仪使用单个测定管进行的,该试管含有抗Kappa IG轻链,Lambda IG轻链,CD19,CD19,CD38,CD45和CD138的抗体。CD38和CD138用于在等离子体细胞上栅极,抗Kappa和抗Lambda用于鉴定细胞质IG光链。流式细胞仪筛查将报告具有免疫球蛋白轻链限制(克隆性)的可检测到的浆细胞群体。(未发表的蛋黄酱方法)
specimens processed: Monday through Sunday
结果报告:星期一至星期五
this test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.
88184-Flow细胞术,细胞表面,细胞质
88185 x 5-Each additional marker
88187-FLOW细胞仪,解释;2到8个标记
test Id | 测试订单名称 | order LOINC Value |
---|---|---|
pbl我 | plasma Cell Assessment, B | 86900-8 |
result Id | test Result Name | result LOINC Value
Applies only to results expressed in units of measure originally reported by the performing laboratory. These values do not apply to results that are converted to other units of measure.
|
---|---|---|
30388 | 血浆细胞轻链 | 86900-8 |
26838 | #单型PC每150,000个活动 | 19099-1 |
26839 | pCevent Interpretation | 69052-9 |
Change Type | effective Date |
---|---|
File Definition - Result ID | 2021-10-26 |